4//SEC Filing
Freeman Roy Lester 4
Accession 0001209191-22-039712
CIK 0001750149other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 9:00 PM ET
Size
5.3 KB
Accession
0001209191-22-039712
Insider Transaction Report
Form 4
Freeman Roy Lester
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-24+40,000→ 40,000 totalExercise: $0.81Exp: 2029-06-24→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This entire stock option grant will vest 100% in a single tranche on the earlier of June 24, 2023 or the day prior to the next annual meeting of stockholders.
Documents
Issuer
Inhibikase Therapeutics, Inc.
CIK 0001750149
Entity typeother
Related Parties
1- filerCIK 0001799732
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 9:00 PM ET
- Size
- 5.3 KB